Pharmacogenomics: A new approach for preventing severe cutaneous adverse drug reactions
© Springer Nature Singapore Pte Ltd. 2018. Pharmacogenomics can be used to identify genetic predisposing factors for serious cutaneous adverse reactions and personalize drug therapy accordingly. Pharmacogenetic screening for severe cutaneous adverse reactions (SCARs) is a key opportunity and potenti...
Saved in:
Main Authors: | Chonlaphat Sukasem, Therdpong Tempark |
---|---|
Other Authors: | Chulalongkorn University |
Format: | Chapter |
Published: |
2019
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/46518 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
Drug-Induced Severe Cutaneous Adverse Reactions: Insights Into Clinical Presentation, Immunopathogenesis, Diagnostic Methods, Treatment, and Pharmacogenomics
by: Therdpong Tempark, et al.
Published: (2022) -
A comprehensive review of hla and severe cutaneous adverse drug reactions: Implication for clinical pharmacogenomics and precision medicine
by: Chiraphat Kloypan, et al.
Published: (2022) -
Drug-Induced Severe Cutaneous Adverse Reactions: Insights Into Clinical Presentation, Immunopathogenesis, Diagnostic Methods, Treatment, and Pharmacogenomics
by: Tempark T.
Published: (2023) -
Genotyping HLA alleles to predict the development of Severe cutaneous adverse drug reactions (SCARs): state-of-the-art
by: Thawinee Jantararoungtong, et al.
Published: (2022) -
Clinical pharmacogenomics and personalized medicine: New strategies to maximize drug efficacy and avoid adverse drug reaction
by: Chonlaphat Sukasem, et al.
Published: (2019)